Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio U Köser

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 2, 2025
More nuance and transparency are needed when setting breakpoints for antimicrobial susceptibility testing of pretomanidClaudio U Köser
The European Respiratory Journal|May 5, 2023
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for <i>Mycobacterium tuberculosis</i> complexClaudio U Köser, Florian P Maurer
The Journal of Antimicrobial Chemotherapy|January 25, 2014
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complexSilke Feuerriegel, Claudio U Köser, Stefan Niemann
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2019
'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanidClaudio U Köser, Florian P Maurer, Katharina Kranzer
Antimicrobial Agents and Chemotherapy|June 24, 2020
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for PyrazinamideClaudio U Köser, Daniela M Cirillo, Paolo Miotto
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2017
Limited Evidence for the Need for Region-Specific, Genotypic Drug-Susceptibility Assays for Mycobacterium tuberculosisClaudio U Köser, Leonardo A Koeser, David L Dolinger
The Journal of Antimicrobial Chemotherapy|March 1, 2013
Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acidSilke Feuerriegel, Claudio U Köser, Elvira Richter, et al.
Trends in Genetics : TIG|August 7, 2014
Whole-genome sequencing to control antimicrobial resistanceClaudio U Köser, Matthew J Ellington, Sharon J Peacock
Nature|April 2, 2011
Microbial sequences benefit health nowEdward J P Cartwright, Claudio U Köser, Sharon J Peacock
Antimicrobial Agents and Chemotherapy|October 16, 2010
Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosisClaudio U Köser, David K Summers, John A C Archer
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 2, 2025
More nuance and transparency are needed when setting breakpoints for antimicrobial susceptibility testing of pretomanidClaudio U Köser
The European Respiratory Journal|May 5, 2023
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for <i>Mycobacterium tuberculosis</i> complexClaudio U Köser, Florian P Maurer
The Journal of Antimicrobial Chemotherapy|January 25, 2014
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complexSilke Feuerriegel, Claudio U Köser, Stefan Niemann
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2019
'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanidClaudio U Köser, Florian P Maurer, Katharina Kranzer
Antimicrobial Agents and Chemotherapy|June 24, 2020
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for PyrazinamideClaudio U Köser, Daniela M Cirillo, Paolo Miotto
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2017
Limited Evidence for the Need for Region-Specific, Genotypic Drug-Susceptibility Assays for Mycobacterium tuberculosisClaudio U Köser, Leonardo A Koeser, David L Dolinger
The Journal of Antimicrobial Chemotherapy|March 1, 2013
Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acidSilke Feuerriegel, Claudio U Köser, Elvira Richter, et al.
Trends in Genetics : TIG|August 7, 2014
Whole-genome sequencing to control antimicrobial resistanceClaudio U Köser, Matthew J Ellington, Sharon J Peacock
Nature|April 2, 2011
Microbial sequences benefit health nowEdward J P Cartwright, Claudio U Köser, Sharon J Peacock
Antimicrobial Agents and Chemotherapy|October 16, 2010
Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosisClaudio U Köser, David K Summers, John A C Archer
Pageof 7